SynthesisClinical rheumatology2007
Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.
Synthesis in Clinical rheumatology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.
- Characteristics and factors associated with treatment response among patients with eosinophilic fasciitis: a systematic review and meta-analysis.Rheumatology international · 2025Pooled it
- Eosinophilic fasciitis.Medicina clinica · 2025Review
- Eosinophilic Fasciitis in a 78-Year-Old Man Following Pembrolizumab Treatment for Bladder Cancer.The American journal of case reports · 2025Article
- Unraveling Shulman's syndrome: A rare case of eosinophilic fasciitis in a pediatric patient with fascial abnormalities on MRI.Radiology case reports · 2025Article
- A Severe Case of Overlap of Morphea and Eosinophilic Fasciitis after Burn Injuries.Case reports in rheumatology · 2024Article
- An unusual case of eosinophilia, myalgia and skin contractures: Shulman's disease revisited.Medical journal, Armed Forces India · 2022Article
- Eosinophilic Fasciitis and Smoldering Multiple Myeloma: An Exceptional Association in Young Adults.Cureus · 2022Article
- Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy.The American journal of case reports · 2021Article
- Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab.Rheumatology international · 2021Article
- The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.Clinical rheumatology · 2020Review
- Eosinophilic Fasciitis - Report of Three Cases and Review of the Literature.Open access Macedonian journal of medical sciences · 2019Article
- A Histologically Proven Case of Autoimmune Hepatitis with Eosinophilic Fasciitis.Internal medicine (Tokyo, Japan) · 2019Article
- Eosinophilic fasciitis (Shulman's disease): review and comparative evaluation of seven patients.Reumatologia · 2019Article
- Eosinophilic fasciitis during pregnancy: case report and review of literature.Rheumatology international · 2018Review
- Eosinophilic fasciitis: a case series with an emphasis on therapy and induction of remission.Drugs in context · 2018Article
- Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.Clinical reviews in allergy & immunology · 2017Review
- Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment.Current rheumatology reports · 2017Review
- Eosinophils in Autoimmune Diseases.Frontiers in immunology · 2017Review
- Eosinophilic Skin Diseases: A Comprehensive Review.Clinical reviews in allergy & immunology · 2016Review
- Scleroderma Mimickers.Current treatment options in rheumatology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We reported two patients with refractory eosinophilic fasciitis (EF) and provided a systematic review of the literature to determine the clinical variables associated with prognosis of EF. We enrolled 88 cases, whose clinical characteristics were analyzed by separating the patients into two or three groups based on outcome. The incidence of certain clinical and pathological features differed among the groups. In particular, the incidence of morphea-like skin lesions in patients with refractory fibrosis was significantly higher than in patients without refractory fibrosis (p = 0.003). Patients with morphea-like skin lesions were 1.9 times more likely to develop persistent fibrosis than patients without these lesions (95% confidence intervals, 1.5-2.5). A younger age (under 12 years) at onset was associated with a 1.6 times greater risk of residual fibrosis (95% confidence interval, 1.1-2.2). Trunk involvement was associated with a 1.4 times greater risk of residual fibrosis (95% confidence interval, 1.0-2.0). Histopathologically, the presence of dermal fibrosclerosis was associated with a 1.4 times greater risk of refractory fibrosis (95% confidence interval, 1.0-2.1). We consider these clinical characteristics, notably the presence of morphea-like skin lesions may be an important risk factor for developing residual fibrosis in EF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.